Terry, Cassandra
Harniman, Robert L.
Sells, Jessica
Wenborn, Adam
Joiner, Susan
Saibil, Helen R.
Miles, Mervyn J.
Collinge, John
Wadsworth, Jonathan D. F. http://orcid.org/0000-0002-4797-2259
Article History
Received: 31 July 2018
Accepted: 23 November 2018
First Online: 23 January 2019
Competing Interests
: J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination, and therapeutics. D-Gen owns the ICSM35 and ICSM18 antibodies used in this study. The other authors declare no potential conflict of interest.